Literature DB >> 19411782

[Clinical significance of dense fine speckled pattern in anti-nuclear antibody test using indirect immunofluorescence method].

So Young Kang1, Woo-In Lee.   

Abstract

BACKGROUND: Dense fine speckled (DFS) pattern in antinuclear antibody (ANA) test using indirect immunofluorescence method became to be known recently and it is detected in patients with various chronic inflammatory diseases as well as in healthy individuals. We investigated the relation between DFS pattern and various diseases.
METHODS: ANA tests by indirect immunofluorescence method using HEp-2 cell line slide (Kallestad; Bio-Rad, USA) were performed in 2,654 patients for screening of systemic autoimmune diseases. The frequencies of ANA and DFS positivity were analyzed according to sex, age, clinical department and disease.
RESULTS: ANA was positive in 13.3% (352/2,654) of the total patients, and the frequency of DFS pattern was observed in 3.8% (101/2,654) of the total patients and in 28.7% (101/352) of the patients with ANA positivity. Higher frequency of DFS positivity was observed in patients referred from Departments of Rheumatology and Nephrology, but there was no difference in the frequencies of DFS positivity among the patients with ANA positivity. The frequency of DFS pattern was higher in seborrheic dermatitis (14.3%), herpes zoster (11.1%), rheumatoid arthritis (16.9%), systemic lupus erythematosus (15.4%) and Sjogren syndrome (14.3%).
CONCLUSIONS: The DFS pattern is a frequent finding (about 28% of ANA positivity) in ANA test using indirect immunofluorescence method. Relatively high frequency of DFS pattern was observed in autoimmune diseases, contrary to the previous observations that DFS pattern is not related with autoimmune diseases. Further studies including the confirmation tests of anti-DFS70 are needed for the identification of relation between DFS pattern and particular diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19411782     DOI: 10.3343/kjlm.2009.29.2.145

Source DB:  PubMed          Journal:  Korean J Lab Med        ISSN: 1598-6535


  10 in total

Review 1.  The Clinical Relevance of Anti-DFS70 Autoantibodies.

Authors:  Karsten Conrad; Nadja Röber; Luis E C Andrade; Michael Mahler
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

2.  Comparative study of immunofluorescent antinuclear antibody test and line immunoassay detecting 15 specific autoantibodies in patients with systemic rheumatic disease.

Authors:  Sun Ah Lee; Jimin Kahng; Yonggoo Kim; Yeon-Joon Park; Kyungja Han; Seung-Ki Kwok; Sung-Hwan Park; Eun-Jee Oh
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

3.  The Prevalence and Clinical Relevance of the DFS Immunofluorescence Staining Pattern in a Large ANA-Positive Cohort.

Authors:  Chuiwen Deng; Anqi Wang; Chaojun Hu; Wen Zhang; Xiaofeng Zeng; Yunyun Fei
Journal:  Front Med (Lausanne)       Date:  2022-05-10

Review 4.  [Antinuclear antibodies without connective tissue disease : Antibodies against LEDGF/DSF70].

Authors:  R Mierau
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

Review 5.  The significance of autoantibodies to DFS70/LEDGFp75 in health and disease: integrating basic science with clinical understanding.

Authors:  Robert L Ochs; Michael Mahler; Anamika Basu; Leslimar Rios-Colon; Tino W Sanchez; Luis E Andrade; Marvin J Fritzler; Carlos A Casiano
Journal:  Clin Exp Med       Date:  2015-06-19       Impact factor: 3.984

6.  Analysis of DFS70 pattern and impact on ANA screening using a novel HEp-2 ELITE/DFS70 knockout substrate.

Authors:  Kishore Malyavantham; Lakshmanan Suresh
Journal:  Auto Immun Highlights       Date:  2017-03-17

7.  Recognition and Relevance of Anti-DFS70 Autoantibodies in Routine Antinuclear Autoantibodies Testing at a Community Hospital.

Authors:  John B Carter; Sara Carter; Sandra Saschenbrecker; Bruce E Goeckeritz
Journal:  Front Med (Lausanne)       Date:  2018-04-09

8.  Simultaneous Distinction of Monospecific and Mixed DFS70 Patterns During ANA Screening with a Novel HEp-2 ELITE/DFS70 Knockout Substrate.

Authors:  Kishore S Malyavantham; Lakshmanan Suresh
Journal:  J Vis Exp       Date:  2018-01-17       Impact factor: 1.355

9.  Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort.

Authors:  Teresa Carbone; Vito Pafundi; Giuseppina Tramontano; Michele Gilio; Maria Carmela Padula; Angela Anna Padula; Salvatore D'Angelo
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

10.  Anti-DFS70 antibodies in systemic lupus erythematosus: Prevalence in a large Chinese cohort and an unexpected association with anti-dsDNA antibodies by a long-term follow-up.

Authors:  Yingxin Dai; Enling Li; Dandan Chen; Xiangyu Niu; Zhiqing Wang; Liangjing Lu; Bing Zheng
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.